Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …

Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …

Introduction: Pertussis is a highly communicable, vaccine-preventable respiratory disease
and a frequent but often underestimated cause of prolonged cough illness in adults …

BACKGROUND: We assessed the seroepidemiology of pertussis, diphtheria and poliovirus
antibodies in a cohort of highly immunized children, together with the burden of these …

Introduction: We undertook a study to evaluate the effectiveness of the National Childhood
Immunisation Programme (NCIP) over the past 26 years by reviewing the epidemiological …

Since the introduction of the pertussis vaccine into the standard immunization program, very
few cases of pertussis have been detected. In 2007, it was felt that the number of cases …

Introduction Pertussis is a worldwide, highly communicable, vaccine‐preventable respiratory
disease and is a frequent but often underestimated cause of prolonged cough illness in …

Pertussis remains a serious problem in many countries. Even in countries with high vaccine
coverage and a long vaccination history, pertussis outbreaks occur periodically. Rather than …

Reduced-antigen, combined diphtheria, tetanus, and acellular pertactin-containing pertussis
vaccine (dTpa; Boostrix™) contains reduced quantities of the same toxoids/antigens found …

Reduced-antigen, combined diphtheria, tetanus, and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …